BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7166185)

  • 1. [Pharmacokinetics and biotransformation of N-propylajmaline hydrogen tartrate in man].
    Hausleiter HJ; Achtert G; Khan MA; Kukovetz WR; Beubler E
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):329-39. PubMed ID: 7166185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of n-propyl-ajmaline-bitartrate in elderly patients with ventricular ectopic activity.
    Elfner R; Achtert G; Hausleiter HJ; Lentz A; Heene DL
    Eur J Drug Metab Pharmacokinet; 1987; 12(1):77-82. PubMed ID: 3609075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidation.
    Zekorn C; Achtert G; Hausleiter HJ; Moon CH; Eichelbaum M
    Klin Wochenschr; 1985 Nov; 63(22):1180-6. PubMed ID: 4079282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics and biotransformation of 14C-lisuride hydrogen maleate in rhesus monkey and in man.
    Hümpel M; Krause W; Hoyer GA; Wendt H; Pommerenke G
    Eur J Drug Metab Pharmacokinet; 1984; 9(4):347-57. PubMed ID: 6532807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics and Antiarrhythmic effects of Prajmalium Bitartrate].
    Trompler AT; Woodcock BG; Bussmann WD
    Arzneimittelforschung; 1983; 33(3):436-9. PubMed ID: 6683519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of the ring-opened N beta-propyl-ajmaline (Neo-Gilurytmal) at physiological pH is obviously responsible for its better absorption and bioavailability when compared with ajmaline (Gilurytmal).
    Hinse C; Stöckigt J
    Pharmazie; 2000 Jul; 55(7):531-2. PubMed ID: 10944783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and metabolic studies of vinpocetine on dogs. I. Pharmacokinetics.
    Szeleczky G; Vereczkey L
    Pol J Pharmacol Pharm; 1986; 38(3):257-67. PubMed ID: 3774624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ambroxol, comparative studies of pharmacokinetics and biotransformation in rat, rabbit, dog and man (author's transl)].
    Hammer R; Bozler G; Jauch R; Koss FW; Hadamovsky H
    Arzneimittelforschung; 1978; 28(5a):899-903. PubMed ID: 581988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of prajmaline (Neo-Gilurytmal) objectifiable by means of a test].
    Fortschr Med; 1983 May; 101(17):809-10. PubMed ID: 6190722
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacokinetics and biotransformation of the new benzodiazepine lormetazepam in humans. I. Absorption, distribution, elimination and metabolism of lormetazepam-5-14C.
    Hümpel M; Illi V; Milius W; Wendt H; Kurowski M
    Eur J Drug Metab Pharmacokinet; 1979; 4(4):237-43. PubMed ID: 43806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of prajmalium bitartrate (Neo-Gilurytmal) in urine with thin layer chromatography].
    Nováková E
    Pharmazie; 1987 Aug; 42(8):550-1. PubMed ID: 3432338
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
    Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
    Schmid J; Busch U; Heinzel G; Bozler G; Kaschke S; Kummer M
    Drug Metab Dispos; 1995 Nov; 23(11):1206-13. PubMed ID: 8591720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
    Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
    Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Localization of the binding site for quaternary derivatives of ajmaline in the Na channel of an excitable membrane].
    Zaborovskaia LD; Khodorov BI
    Biull Eksp Biol Med; 1985 Sep; 100(9):297-9. PubMed ID: 2412613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
    Nave R; Bethke TD; van Marle SP; Zech K
    Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of remoxipride in different species. Species differences in metabolism.
    Widman M; Nilsson LB; Bryske B; Lundström J
    Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of Neo-Gilurytmal on heart lesions induced with isoprenaline].
    Mitova M; Bednarík B; Foukal T; Papousek F; Cerný E
    Cesk Patol; 1986 May; 22(2):116-20. PubMed ID: 3731295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic studies of the antiarrhythmic drugs ajmaline and N-propylajmaline bitartrate in dogs.
    Anttila M; Tikkanen R; Nieminen L
    Arzneimittelforschung; 1978; 28(3):397-9. PubMed ID: 580746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of Neo-Gilurytmal on the excitation-conduction system of the human heart].
    Trusz-Gluza M; Giec L; Zajac T; Kocot A; Hübner D; Kośmider J
    Kardiol Pol; 1982; 25(9):703-8. PubMed ID: 7169756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.